← Back to Search

Behavioural Intervention

SMA Neurofeedback for Tourette Syndrome

N/A
Recruiting
Led By Michelle Hampson, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and one month post-nf
Awards & highlights

Study Summary

This trial is testing whether neurofeedback from the supplementary motor area can help reduce tics in adolescents with Tourette Syndrome.

Who is the study for?
This trial is for boys and girls aged 10-16 with Tourette Syndrome or chronic tic disorder, who can perform tics without moving their head. They must have a certain score on the YGTSS scale, be stable on current medications, live within 2 hours of Yale Medical Center, speak English, and not have metal implants/braces or claustrophobia.Check my eligibility
What is being tested?
Adolescents are randomly assigned to receive either real neurofeedback from the supplementary motor area (SMA) or from a control region using fMRI technology. The goal is to see if targeting the SMA helps manage symptoms of Tourette Syndrome better than the control.See study design
What are the potential side effects?
Since this trial involves non-invasive fMRI neurofeedback rather than medication, traditional side effects are minimal. However, participants may experience discomfort due to lying still in an MRI machine and potential anxiety related to claustrophobia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and one month post-nf
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and one month post-nf for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in symptoms after the intervention compared to baseline
Secondary outcome measures
Change in control over activity in the SMA target region during NF compared to baseline
Other outcome measures
Changes in resting state functional connectivity to SMA in NF group

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Neurofeedback from the SMAExperimental Treatment1 Intervention
Group II: Neurofeedback from control regionActive Control1 Intervention

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,784 Previous Clinical Trials
2,689,213 Total Patients Enrolled
13 Trials studying Tourette Syndrome
3,275 Patients Enrolled for Tourette Syndrome
Yale UniversityLead Sponsor
1,848 Previous Clinical Trials
2,737,754 Total Patients Enrolled
12 Trials studying Tourette Syndrome
539 Patients Enrolled for Tourette Syndrome
Michelle Hampson, PhDPrincipal InvestigatorYale University
3 Previous Clinical Trials
74 Total Patients Enrolled

Media Library

Neurofeedback from the SMA (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05558566 — N/A
Tourette Syndrome Research Study Groups: Neurofeedback from the SMA, Neurofeedback from control region
Tourette Syndrome Clinical Trial 2023: Neurofeedback from the SMA Highlights & Side Effects. Trial Name: NCT05558566 — N/A
Neurofeedback from the SMA (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05558566 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the participant count of this clinical experiment?

"Affirmative. Clinicaltrials.gov corroborates that this clinical trial is currently attempting to find 64 participants from 1 medical site. This research was posted on November 1st 2022 with the last update occurring on November 21st 2022."

Answered by AI

Is the cutoff age for enrolment in this research endeavour higher than 85 years old?

"The requirements for participation in this experiment indicates that the age of participants must be between 10 and 16 years old. Furthermore, there are 382 clinical trials designed specifically for youngsters under 18, as well as 990 for senior citizens over 65."

Answered by AI

Are any volunteers being sought for this trial at this time?

"Indeed, clinicaltrials.gov reveals that this medical trial is still recruiting participants since its inception on November 1st 2022. The investigation has been updated recently and requires 64 patients to be enrolled across one site."

Answered by AI

Could I potentially qualify to join this medical experiment?

"This study seeks a total of 64 patients suffering from Gilles de la Tourette syndrome aged between 10 and 16."

Answered by AI

Who else is applying?

What site did they apply to?
Yale University School of Medicine
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Neurofeedback From the Supplementary Motor Area for Tourette Syndrome
2022. "Neurofeedback From the Supplementary Motor Area for Tourette Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05558566.
All > Tourette Syndrome
~42 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top